Is zealandpharma.com Safe? Security Analysis for Zealand pharma a/s
http://zealandpharma.comCheck if zealandpharma.com is a scam or legitimate. Free security scan and reviews.
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for zealandpharma.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
5 urgent findings need attention
5 high
Keep zealandpharma.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
3 findings
70/100
GDPR Compliance
2 findings
83/100
NIS2 Compliance
8 findings
17/100
Email Security
1 finding
0/100
Security scan incomplete. 4 out of 9 security checks failed to complete. The website may be inaccessible or protected by security measures. Please retry the scan or verify the website is accessible.
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Zealand Pharma operates in the healthcare biotechnology sector with a focus on peptide therapeutics. Its business model revolves around innovative drug development, partnering, and investor engagement. The company targets chronic and rare diseases with unmet needs, positioning itself as a specialized player in peptide-based medicines. Revenue streams likely include licensing, partnerships, and product development. The website indicates active investor relations and corporate governance, suggesting a publicly traded entity. Partnerships with shareholder services and external job portals indicate a robust operational ecosystem. Growth indicators include recent clinical trial announcements and regulatory submissions. The company maintains a strong brand consistency and trust signals through Nasdaq listing and scientific publications.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a good security maturity level with HTTPS enabled and cookie consent mechanisms in place. No exposed sensitive data or vulnerable libraries were detected in the provided content. However, the absence of a published security policy, incident response information, and vulnerability disclosure reduces transparency and preparedness perception. There is no evidence of a security.txt file or data protection officer contact, which are best practices for compliance and incident handling. Overall, the security posture is solid but could be improved by adding explicit security governance documentation and contact channels.
Strategic Recommendations
Priority Actions for Security Improvement
Publish a dedicated security policy page outlining security practices and compliance.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Zealand Pharma
Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs
excellent
consistent
Technical Stack
moderate
good
good
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism
- No exposed sensitive data detected
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with rich content and professional design.
Get this report delivered to your inbox
Receive a summary of the zealandpharma.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Weak Referrer-Policy configuration
LOWCurrent value: "same-origin"
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete zealandpharma.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
How does zealandpharma.com compare?
zealandpharma.com scores below average. Browse similar domains to see how competitors handle security.
Download the zealandpharma.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Want OffSeq to fix this?
Book a 30-minute remediation call
Our security engineers can resolve the critical-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.
OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services
Scan your own website
Liked the zealandpharma.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about zealandpharma.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published